|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 109, Issue 3 643-652, Copyright © 1996 by Company of Biologists
JOURNAL ARTICLES |
EI Deryugina and MA Bourdon
La Jolla Institute for Experimental Medicine, California 92037, USA.
The role of tenascin in mediating tumor cell migration was studied using two cell migration models. In migration/invasion Transwell assays U251.3 glioma cells rapidly migrated through the 8 mu m pore size membranes onto tenascin- and fibronectin-coated surfaces. In this assay the number of cells migrating onto tenascin was 52.2 +/- 9.6% greater than on fibronectin within 4 hours. To assess cell migration rates and cell morphology, U251.3 migration was examined in a two-dimension spheroid outgrowth assay. The radial distance migrated by U251.3 cells from tumor spheroids was found to be 53.8 +/- 4.9% greater on tenascin than on fibronectin. Cells migrating on tenascin display a very motile appearance, while cells migrating on fibronectin spread and maintain close intercellular contacts. Cell migration in the presence of integrin blocking antibodies demonstrated that migration on tenascin and fibronectin is mediated by distinct integrins, alpha2beta1 and alphavbeta5/alphavbeta3, respectively. Since tenascin is coexpressed in malignant tumor matrices with fibronectin, we assessed the effects of tenascin on U251.3 cell migration mediated by fibronectin. Tenascin was found to provide a positive effect on fibronectin-mediated migration by altering cell morphology and enhancing cell motility. These effects of tenascin on fibronectin-mediated cell migration were inhibited by blocking beta1 and alpha2beta1 integrins. The results suggest that tenascin may play a significant role in promoting tumor cell migration and invasiveness by modulating cell responses to normal matrix components.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  T. A. Ulrich, E. M. de Juan Pardo, and S. Kumar The Mechanical Rigidity of the Extracellular Matrix Regulates the Structure, Motility, and Proliferation of Glioma Cells Cancer Res., May 15, 2009; 69(10): 4167 - 4174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Piao, L. Lu, and J. de Groot AMPA receptors promote perivascular glioma invasion via {beta}1 integrin-dependent adhesion to the extracellular matrix Neuro-oncol, January 1, 2009; 11(3): 260 - 273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sarkar, R. K. Nuttall, S. Liu, D. R. Edwards, and V. W. Yong Tenascin-C Stimulates Glioma Cell Invasion through Matrix Metalloproteinase-12 Cancer Res., December 15, 2006; 66(24): 11771 - 11780. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Luo, E. Ko, J. C.-f. Hsu, X. Wang, and S. Ferrone Targeting Melanoma Cells with Human High Molecular Weight-Melanoma Associated Antigen-Specific Antibodies Elicited by a Peptide Mimotope: Functional Effects J. Immunol., May 15, 2006; 176(10): 6046 - 6054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Akabani, D. A. Reardon, R. E. Coleman, T. Z. Wong, S. D. Metzler, J. E. Bowsher, D. P. Barboriak, J. M. Provenzale, K. L. Greer, D. DeLong, et al. Dosimetry and Radiographic Analysis of 131I-Labeled Anti-Tenascin 81C6 Murine Monoclonal Antibody in Newly Diagnosed Patients with Malignant Gliomas: A Phase II Study J. Nucl. Med., June 1, 2005; 46(6): 1042 - 1051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Lefranc, J. Brotchi, and R. Kiss Possible Future Issues in the Treatment of Glioblastomas: Special Emphasis on Cell Migration and the Resistance of Migrating Glioblastoma Cells to Apoptosis J. Clin. Oncol., April 1, 2005; 23(10): 2411 - 2422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Liao, W.-y. Bu, T.-H. Wang, S. Ahmed, and Z.-C. Xiao Tenascin-R Plays a Role in Neuroprotection via Its Distinct Domains That Coordinate to Modulate the Microglia Function J. Biol. Chem., March 4, 2005; 280(9): 8316 - 8323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Zagzag, B. Shiff, G. I. Jallo, M. A. Greco, C. Blanco, H. Cohen, J. Hukin, J. C. Allen, and D. R. Friedlander Tenascin-C Promotes Microvascular Cell Migration and Phosphorylation of Focal Adhesion Kinase Cancer Res., May 1, 2002; 62(9): 2660 - 2668. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. I. Deryugina, L. Soroceanu, and A. Y. Strongin Up-Regulation of Vascular Endothelial Growth Factor by Membrane-type 1 Matrix Metalloproteinase Stimulates Human Glioma Xenograft Growth and Angiogenesis Cancer Res., January 1, 2002; 62(2): 580 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Schenk, R. Chiquet-Ehrismann, and E. J. Battegay The Fibrinogen Globe of Tenascin-C Promotes Basic Fibroblast Growth Factor-induced Endothelial Cell Elongation Mol. Biol. Cell, September 1, 1999; 10(9): 2933 - 2943. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Talts, G Wirl, M Dictor, W. Muller, and R Fassler Tenascin-C modulates tumor stroma and monocyte/macrophage recruitment but not tumor growth or metastasis in a mouse strain with spontaneous mammary cancer J. Cell Sci., January 6, 1999; 112(12): 1855 - 1864. [Abstract] [PDF]
|
|
|
|
|
|
J. A. Luczak, S. D. Redick, and J. E. Schwarzbauer A Single Cysteine, Cys-64, Is Essential for Assembly of Tenascin-C Hexabrachions J. Biol. Chem., January 23, 1998; 273(4): 2073 - 2077. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Phillips, L. Krushel, and K. Crossin Domains of tenascin involved in glioma migration J. Cell Sci., January 4, 1998; 111(8): 1095 - 1104. [Abstract] [PDF]
|
|
|
|
|
|
D. W. LaFleur, J. Chiang, J. A. Fagin, S. M. Schwartz, P. K. Shah, K. Wallner, J. S. Forrester, and B. G. Sharifi Aortic Smooth Muscle Cells Interact with Tenascin-C through Its Fibrinogen-like Domain J. Biol. Chem., December 26, 1997; 272(52): 32798 - 32803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Deryugina, M. Bourdon, G. Luo, R. Reisfeld, and A Strongin Matrix metalloproteinase-2 activation modulates glioma cell migration J. Cell Sci., January 10, 1997; 110(19): 2473 - 2482. [Abstract] [PDF]
|
|
